跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOMETASONA ARISTO 50 MICROGRAMOS/PULVERIZACION SUSPENSIÓN PARA PULVERIZACIÓN NASAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MOMETASONA ARISTO 50 MICROGRAMOS/PULVERIZACION SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Approved
STANDARD
MOMETASONA ARISTO 50 MICROGRAMOS/PULVERIZACION SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Aristo Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 13, 2024
Approval ID
f2ed60eda8956c53
Company
Aristo Pharma Gmbh
Type
Standard
Approval Details
Approval Id
f2ed60eda8956c53
Drug Cima Aemps Name
MOMETASONA ARISTO 50 MICROGRAMOS/PULVERIZACION SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Register Number
89444
Holder Company Name
Aristo Pharma Gmbh
Marketing Company Name
Aristo Pharma Iberia S.L.
Holder Company Detail Path
/organization/aristo-pharma-gmbh
Authorization Date
2024-03-13
Dosage Form
SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose
50 microgramos
Route Of Administration
VÍA NASAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Aristo Pharma Gmbh
Company Detail Path
/organization/aristo-pharma-gmbh
Company Information
Pharmaceutical Company Name
Aristo Pharma GmbH
Country Name
Germany
Website
http://www.aristo-pharma.de
Active Ingredients
MOMETASONA FUROATO MONOHIDRATO
0,052 mg/pulsación
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 13, 2024
Approval ID
f2ed60eda8956c53
Type
Standard
Back to CIMA-AEMPS Approvals